Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Updated on: September 10,2024 0

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Updated on:September 10,2024 0

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on: October 15,2023 163

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on:October 15,2023 163

Delving where few others have gone, leukemia researchers open new path

byUniversity of Rochester Medical CenterCredit: CC0 Public DomainA Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadlies

Updated on: December 18,2023 18

Delving where few others have gone, leukemia researchers open new path

byUniversity of Rochester Medical CenterCredit: CC0 Public DomainA Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadlies

Updated on:December 18,2023 18

Diversity is everyone's responsibility: Researchers outline a path to representation in cancer clinical trials

byAmerican Society of HematologyCredit: CC0 Public DomainA new study published today inBlood Advancesoutlines practical strategies for promoting diversity, equity, inclusion, and acc

Updated on: December 21,2023 10

Diversity is everyone's responsibility: Researchers outline a path to representation in cancer clinical trials

byAmerican Society of HematologyCredit: CC0 Public DomainA new study published today inBlood Advancesoutlines practical strategies for promoting diversity, equity, inclusion, and acc

Updated on:December 21,2023 10

A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

byUniversity of California, Los AngelesPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteA four-drug chemotherapy regimen provided l

Updated on: January 04,2024 8

A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

byUniversity of California, Los AngelesPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteA four-drug chemotherapy regimen provided l

Updated on:January 04,2024 8

Measuring 'quality of life' is an important trend in cancer care

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit

Updated on: August 27,2024 0

Measuring 'quality of life' is an important trend in cancer care

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit

Updated on:August 27,2024 0

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on: March 20,2024 13

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on:March 20,2024 13

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize

Updated on: December 18,2023 10

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize

Updated on:December 18,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023 10

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on: January 06,2024 15

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on:January 06,2024 15

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023 10

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023 10

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy

Updated on: December 18,2023 11

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy

Updated on:December 18,2023 11